MedPharm || طبصيدلة
前往频道在 Telegram
شرح مادة الصيدلة السريرية clinical pharmacology 🧑🏻⚕️ معرف التلي: mohammedsalim10 Instagram: _a1mh
显示更多未指定国家未指定类别
3 508
订阅者
-324 小时
-157 天
-5830 天
帖子存档
3 508
Concerning Alzheimer disease, The non-pharmacological approaches for managing the behavioral symptoms in patients with dementia involve all the following EXCEPT:
3 508
Alzheimer disease is a progressive illness. N pathophysiology nitters involved in. of Alzheimer disease
3 508
Alzheimer disease, there are many clinical symptoms will associate with it. The main change in personality and behavior that associated with Alzheimer disease: The main
3 508
Cholinesterase inhibitors and NMDA-receptor antagonists are indicated for treatment of Alzheimer Disease. Which drug blocks glutamatergic neurotransmission by antagonizing NMDA receptors
3 508
13) Which of the following drugs is preffered in the management of anxiety and apathy in patient with Alzheimer disease?
3 508
12) Which of the following drugs is not recommended to prevent or treat dementia?
3 508
10) All the following are the adverse effects of cholinesterase inhibitors except:
3 508
9) 70 years male with Alzheimer disease he was taken drug for his cognitive symptoms and after 1 month he was hospitilized due to Stevens– Johnson syndrome which of the following drugs the patient was use?
3 508
8) Which of the following drugs is indicated for severe Alzheimer disease?
3 508
7) The goals of treatment of Alzheimer disease include the following except:
3 508
6) All the following drugs can cause dementia symptoms except:
3 508
5) Which of the following can be used to identify structural abnormalities consistent with Alzheimer dises?
3 508
4) Patient loses ability to speak, walk, and feed self and require care 24 hours a day MMSE score is:
3 508
3) Which of the following is the most prominent neurotransmitter deficit that correlates with Alzheimer severity?
3 508
1) All the following are the risk factors of Alzheimer disease except:
